nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Trauma—Prednisolone—ankylosing spondylitis	0.0317	0.0317	CcSEcCtD
Methocarbamol—Trauma—Triamcinolone—ankylosing spondylitis	0.0292	0.0292	CcSEcCtD
Methocarbamol—Trauma—Methylprednisolone—ankylosing spondylitis	0.0291	0.0291	CcSEcCtD
Methocarbamol—Taste metallic—Methotrexate—ankylosing spondylitis	0.0289	0.0289	CcSEcCtD
Methocarbamol—Trauma—Dexamethasone—ankylosing spondylitis	0.0265	0.0265	CcSEcCtD
Methocarbamol—Trauma—Betamethasone—ankylosing spondylitis	0.0265	0.0265	CcSEcCtD
Methocarbamol—Trauma—Prednisone—ankylosing spondylitis	0.0231	0.0231	CcSEcCtD
Methocarbamol—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.0127	0.0127	CcSEcCtD
Methocarbamol—Injury—Prednisolone—ankylosing spondylitis	0.0119	0.0119	CcSEcCtD
Methocarbamol—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.0116	0.0116	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.0116	0.0116	CcSEcCtD
Methocarbamol—Injury—Triamcinolone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Methocarbamol—Injury—Methylprednisolone—ankylosing spondylitis	0.0109	0.0109	CcSEcCtD
Methocarbamol—Amnesia—Methylprednisolone—ankylosing spondylitis	0.0107	0.0107	CcSEcCtD
Methocarbamol—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.0106	0.0106	CcSEcCtD
Methocarbamol—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.0106	0.0106	CcSEcCtD
Methocarbamol—Injury—Dexamethasone—ankylosing spondylitis	0.00996	0.00996	CcSEcCtD
Methocarbamol—Injury—Betamethasone—ankylosing spondylitis	0.00996	0.00996	CcSEcCtD
Methocarbamol—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.00921	0.00921	CcSEcCtD
Methocarbamol—Injury—Prednisone—ankylosing spondylitis	0.00867	0.00867	CcSEcCtD
Methocarbamol—Amnesia—Prednisone—ankylosing spondylitis	0.00848	0.00848	CcSEcCtD
Methocarbamol—Conjunctivitis—Prednisolone—ankylosing spondylitis	0.00821	0.00821	CcSEcCtD
Methocarbamol—Bradycardia—Prednisolone—ankylosing spondylitis	0.00772	0.00772	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00769	0.00769	CcSEcCtD
Methocarbamol—Conjunctivitis—Triamcinolone—ankylosing spondylitis	0.00755	0.00755	CcSEcCtD
Methocarbamol—Bradycardia—Triamcinolone—ankylosing spondylitis	0.0071	0.0071	CcSEcCtD
Methocarbamol—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00709	0.00709	CcSEcCtD
Methocarbamol—Conjunctivitis—Betamethasone—ankylosing spondylitis	0.00685	0.00685	CcSEcCtD
Methocarbamol—Conjunctivitis—Dexamethasone—ankylosing spondylitis	0.00685	0.00685	CcSEcCtD
Methocarbamol—Bradycardia—Betamethasone—ankylosing spondylitis	0.00644	0.00644	CcSEcCtD
Methocarbamol—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00644	0.00644	CcSEcCtD
Methocarbamol—Vision blurred—Prednisolone—ankylosing spondylitis	0.00622	0.00622	CcSEcCtD
Methocarbamol—Angioedema—Prednisolone—ankylosing spondylitis	0.00603	0.00603	CcSEcCtD
Methocarbamol—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00595	0.00595	CcSEcCtD
Methocarbamol—Vertigo—Prednisolone—ankylosing spondylitis	0.00593	0.00593	CcSEcCtD
Methocarbamol—Syncope—Prednisolone—ankylosing spondylitis	0.00592	0.00592	CcSEcCtD
Methocarbamol—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.0058	0.0058	CcSEcCtD
Methocarbamol—Convulsion—Prednisolone—ankylosing spondylitis	0.00572	0.00572	CcSEcCtD
Methocarbamol—Bradycardia—Prednisone—ankylosing spondylitis	0.00561	0.00561	CcSEcCtD
Methocarbamol—Angioedema—Triamcinolone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Methocarbamol—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00554	0.00554	CcSEcCtD
Methocarbamol—Vertigo—Triamcinolone—ankylosing spondylitis	0.00546	0.00546	CcSEcCtD
Methocarbamol—Syncope—Triamcinolone—ankylosing spondylitis	0.00545	0.00545	CcSEcCtD
Methocarbamol—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00544	0.00544	CcSEcCtD
Methocarbamol—Syncope—Methylprednisolone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Methocarbamol—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00539	0.00539	CcSEcCtD
Methocarbamol—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00534	0.00534	CcSEcCtD
Methocarbamol—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Methocarbamol—Shock—Prednisolone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Methocarbamol—Convulsion—Triamcinolone—ankylosing spondylitis	0.00526	0.00526	CcSEcCtD
Methocarbamol—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00525	0.00525	CcSEcCtD
Methocarbamol—Drowsiness—Methotrexate—ankylosing spondylitis	0.00513	0.00513	CcSEcCtD
Methocarbamol—Flushing—Prednisone—ankylosing spondylitis	0.00512	0.00512	CcSEcCtD
Methocarbamol—Angioedema—Betamethasone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Methocarbamol—Angioedema—Dexamethasone—ankylosing spondylitis	0.00504	0.00504	CcSEcCtD
Methocarbamol—Conjunctivitis—Methotrexate—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Methocarbamol—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00499	0.00499	CcSEcCtD
Methocarbamol—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00496	0.00496	CcSEcCtD
Methocarbamol—Vertigo—Betamethasone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Methocarbamol—Vertigo—Dexamethasone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Methocarbamol—Syncope—Betamethasone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Methocarbamol—Syncope—Dexamethasone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Methocarbamol—Shock—Triamcinolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Methocarbamol—Insomnia—Prednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Methocarbamol—Shock—Methylprednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Methocarbamol—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Methocarbamol—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Methocarbamol—Convulsion—Betamethasone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Methocarbamol—Convulsion—Dexamethasone—ankylosing spondylitis	0.00477	0.00477	CcSEcCtD
Methocarbamol—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Methocarbamol—Pain—Prednisolone—ankylosing spondylitis	0.00461	0.00461	CcSEcCtD
Methocarbamol—Vision blurred—Prednisone—ankylosing spondylitis	0.00452	0.00452	CcSEcCtD
Methocarbamol—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Methocarbamol—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.0045	0.0045	CcSEcCtD
Methocarbamol—Insomnia—Triamcinolone—ankylosing spondylitis	0.00448	0.00448	CcSEcCtD
Methocarbamol—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00447	0.00447	CcSEcCtD
Methocarbamol—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Methocarbamol—Shock—Dexamethasone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Methocarbamol—Shock—Betamethasone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Methocarbamol—Angioedema—Prednisone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Methocarbamol—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Methocarbamol—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00435	0.00435	CcSEcCtD
Methocarbamol—Vertigo—Prednisone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Methocarbamol—Syncope—Prednisone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Methocarbamol—Urticaria—Prednisolone—ankylosing spondylitis	0.00428	0.00428	CcSEcCtD
Methocarbamol—Pain—Triamcinolone—ankylosing spondylitis	0.00424	0.00424	CcSEcCtD
Methocarbamol—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Methocarbamol—Hypotension—Dexamethasone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Methocarbamol—Hypotension—Betamethasone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Methocarbamol—Convulsion—Prednisone—ankylosing spondylitis	0.00416	0.00416	CcSEcCtD
Methocarbamol—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Methocarbamol—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Methocarbamol—Insomnia—Dexamethasone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Methocarbamol—Insomnia—Betamethasone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Methocarbamol—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00397	0.00397	CcSEcCtD
Methocarbamol—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Methocarbamol—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00396	0.00396	CcSEcCtD
Methocarbamol—Urticaria—Triamcinolone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Methocarbamol—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Methocarbamol—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Methocarbamol—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Methocarbamol—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Methocarbamol—Shock—Prednisone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Methocarbamol—Pain—Dexamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Methocarbamol—Pain—Betamethasone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Methocarbamol—Vision blurred—Methotrexate—ankylosing spondylitis	0.00378	0.00378	CcSEcCtD
Methocarbamol—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Methocarbamol—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Methocarbamol—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Methocarbamol—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00364	0.00364	CcSEcCtD
Methocarbamol—Vertigo—Methotrexate—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Methocarbamol—Leukopenia—Methotrexate—ankylosing spondylitis	0.00359	0.00359	CcSEcCtD
Methocarbamol—Urticaria—Dexamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Methocarbamol—Urticaria—Betamethasone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Methocarbamol—Dizziness—Prednisolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Methocarbamol—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Methocarbamol—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Methocarbamol—Insomnia—Prednisone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Methocarbamol—Pruritus—Triamcinolone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Methocarbamol—Pruritus—Methylprednisolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Methocarbamol—Convulsion—Methotrexate—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Methocarbamol—Dyspepsia—Prednisone—ankylosing spondylitis	0.00345	0.00345	CcSEcCtD
Methocarbamol—Rash—Prednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Methocarbamol—Dermatitis—Prednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Methocarbamol—Headache—Prednisolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Methocarbamol—Confusional state—Methotrexate—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Methocarbamol—Dizziness—Triamcinolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Methocarbamol—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Methocarbamol—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00323	0.00323	CcSEcCtD
Methocarbamol—Nausea—Prednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Methocarbamol—Pruritus—Dexamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Methocarbamol—Pruritus—Betamethasone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Methocarbamol—Vomiting—Triamcinolone—ankylosing spondylitis	0.00315	0.00315	CcSEcCtD
Methocarbamol—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Methocarbamol—Rash—Triamcinolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Methocarbamol—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Methocarbamol—Rash—Methylprednisolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Methocarbamol—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Methocarbamol—Urticaria—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Methocarbamol—Headache—Triamcinolone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Methocarbamol—Headache—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Methocarbamol—Body temperature increased—Prednisone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Methocarbamol—Hypotension—Methotrexate—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Methocarbamol—Dizziness—Betamethasone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Methocarbamol—Dizziness—Dexamethasone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Methocarbamol—Insomnia—Methotrexate—ankylosing spondylitis	0.00296	0.00296	CcSEcCtD
Methocarbamol—Nausea—Triamcinolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Methocarbamol—Nausea—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Methocarbamol—Somnolence—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Methocarbamol—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Methocarbamol—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00288	0.00288	CcSEcCtD
Methocarbamol—Vomiting—Dexamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Methocarbamol—Vomiting—Betamethasone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Methocarbamol—Rash—Betamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Methocarbamol—Rash—Dexamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Methocarbamol—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Methocarbamol—Dermatitis—Betamethasone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Methocarbamol—Headache—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Methocarbamol—Headache—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Methocarbamol—Pain—Methotrexate—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Methocarbamol—Pruritus—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Methocarbamol—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.0027	0.0027	CcSEcCtD
Methocarbamol—Nausea—Dexamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Methocarbamol—Nausea—Betamethasone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Methocarbamol—Urticaria—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Methocarbamol—Dizziness—Prednisone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Methocarbamol—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Methocarbamol—Vomiting—Prednisone—ankylosing spondylitis	0.00249	0.00249	CcSEcCtD
Methocarbamol—Rash—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Methocarbamol—Dermatitis—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Methocarbamol—Headache—Prednisone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Methocarbamol—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Methocarbamol—Nausea—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Methocarbamol—Pruritus—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Methocarbamol—Dizziness—Methotrexate—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Methocarbamol—Vomiting—Methotrexate—ankylosing spondylitis	0.00208	0.00208	CcSEcCtD
Methocarbamol—Rash—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Methocarbamol—Dermatitis—Methotrexate—ankylosing spondylitis	0.00206	0.00206	CcSEcCtD
Methocarbamol—Headache—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Methocarbamol—Nausea—Methotrexate—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
